The drug olaparib has now been used to treat over 140,000 patients globally, changing the outlook for people with breast, ovarian, prostate and pancreatic cancers. Professor Sir Steve Jackson talks about chance, risk, curiosity and shots-on-goal in the journey of his discovery.
Find out more here -https://preview.shorthand.com/yGfBcYGGioylmQVK
Find out more here -https://preview.shorthand.com/yGfBcYGGioylmQVK
- Category
- Academic
- Tags
- Cambridge University, Cambridge research
Sign in or sign up to post comments.
Be the first to comment